Within the nucleus, PD-L1 transactivates multiple pro-inflammatory and immune response transcription factors that are also regulated by ATR activation, building up a positive feedback loop that further increases nuclear PD-L1 expression and foster tumor immune evasion. The gene discussed is CD274; the disease is neoplasm.